HCV-specific STAR fusions (Altor bioscience)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHCV-specific STAR fusions (Altor bioscience)
Drug Alias NameSTAR fusions agents (Altor)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsHepatitis CCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe General Hospital Corporation D/B/A Massachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe General Hospital Corporation D/B/A Massachusetts General HospitalAltor Bioscience Corp
Active IndicationsN/A
Inactive IndicationsHepatitis CCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A